MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cholinergic deficits in Parkinson Disease

R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

Meeting: 2023 International Congress

Abstract Number: 1504

Keywords: Acetylcholine, Dementia, Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: To determine whether loss of cholinergic projections to cortical and limbic regions contributes to the development of dementia in Parkinson’s disease (PD).

Background: PD is defined by the accumulation of aggregated alpha synuclein (Asyn) in Lewy bodies and Lewy neurites. As high as 80 percent of PD patients eventually develop dementia, which is associated with neocortical accumulation of Asyn and referred to as Lewy Body Dementia (LBD). However, neuronal loss and Asyn accumulation also occur in multiple subcortical nuclei, including cholinergic neurons in the nucleus basalis of Meynert, which have widespread projections to cortical and limbic regions.

Method: In this study, we analyzed a marker of cholinergic innervation in 8 different brain regions from PD autopsy cases with and without dementia. For comparison, we also analyzed the same 8 brain regions from control autopsy cases. We used sandwich ELISAs to analyze each brain region for choline acetyltransferase (ChAT), the enzyme responsible for acetylcholine synthesis.

Results: We observed significantly lower ChAT levels in PD compared to control cases for the five cortical regions that we analyzed. ChAT levels in cortical regions were lower in PD cases with dementia compared to those without dementia. Furthermore, the sum of ChAT levels in the five cortical regions inversely correlated with the Clinical Dementia Rating (CDR) sum of boxes score, a measure of global cognitive impairment.

Conclusion: These results indicate a role for the loss of cholinergic projections to cortical regions in the development of cognitive impairment in PD.

To cite this abstract in AMA style:

R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer. Cholinergic deficits in Parkinson Disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/cholinergic-deficits-in-parkinson-disease/. Accessed September 21, 2023.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cholinergic-deficits-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • #22892 (not found)
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley